These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23695789)

  • 1. [Biomarker research in neuropsychiatry: challenges and potential].
    Gottschalk MG; Schwarz E; Bahn S
    Fortschr Neurol Psychiatr; 2013 May; 81(5):243-9. PubMed ID: 23695789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market.
    Bahn S; Noll R; Barnes A; Schwarz E; Guest PC
    Int Rev Neurobiol; 2011; 101():299-327. PubMed ID: 22050857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood test for schizophrenia.
    Tomasik J; Schwarz E; Guest PC; Bahn S
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S79-83. PubMed ID: 22923188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker identification in psychiatric disorders: from neuroscience to clinical practice.
    Razafsha M; Khaku A; Azari H; Alawieh A; Behforuzi H; Fadlallah B; Kobeissy FH; Wang KK; Gold MS
    J Psychiatr Pract; 2015 Jan; 21(1):37-48. PubMed ID: 25603450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.
    Chan MK; Gottschalk MG; Haenisch F; Tomasik J; Ruland T; Rahmoune H; Guest PC; Bahn S
    Prog Neurobiol; 2014 Nov; 122():45-72. PubMed ID: 25173695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How far have biomarkers in psychiatry advanced?].
    Hashimoto R; Yasuda Y; Yamamori H; Fujimoto M; Ohi K; Fukumoto M; Umeda-Yano S; Takeda M
    Seishin Shinkeigaku Zasshi; 2013; 115(12):1203-10. PubMed ID: 24601093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
    Lowe CR
    Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of multiplexed assay systems for molecular diagnostics.
    Schwarz E; VanBeveren NJ; Guest PC; Izmailov R; Bahn S
    Int Rev Neurobiol; 2011; 101():259-78. PubMed ID: 22050855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
    Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
    Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum-based biomarkers for psychiatric disorders].
    Bahn S; Schwarz E
    Nervenarzt; 2011 Nov; 82(11):1395-6, 1398, 1400 passim. PubMed ID: 21909807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of fatty acid and lipid measurements in neuropsychiatry.
    Grela A; Rachel W; Cole M; Zyss T; Zięba A; Piekoszewski W
    Clin Chem Lab Med; 2016 Feb; 54(2):197-206. PubMed ID: 26351933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.
    Schwarz E; Bahn S
    Expert Rev Mol Diagn; 2008 Mar; 8(2):209-16. PubMed ID: 18366307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.
    Kluge W; Alsaif M; Guest PC; Schwarz E; Bahn S
    Expert Rev Mol Diagn; 2011 Sep; 11(7):721-33. PubMed ID: 21902534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges.
    McCullumsmith RE; Meador-Woodruff JH
    Biol Psychiatry; 2011 Jan; 69(2):127-33. PubMed ID: 21094488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic approaches to unravel the complexity of schizophrenia.
    Martins-de-Souza D; Guest PC; Rahmoune H; Bahn S
    Expert Rev Proteomics; 2012; 9(1):97-108. PubMed ID: 22292827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive neuropsychiatry: conceptual, methodological and philosophical perspectives.
    Hohwy J; Rosenberg R
    World J Biol Psychiatry; 2005; 6(3):192-7. PubMed ID: 16166028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How biomarkers will change psychiatry. Part II: Biomarker selection and potential inflammatory markers of depression.
    Macaluso M; Drevets WC; Preskorn SH
    J Psychiatr Pract; 2012 Jul; 18(4):281-6. PubMed ID: 22805902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.